Literature DB >> 1370062

Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36).

F C Stomski1, J S Gani, R C Bates, G F Burns.   

Abstract

Fetal embryonic fibroblasts attach and spread on thrombospondin (TSP). Adhesion is tight and focal adhesion plaques and "spots" are formed. We have investigated the receptors responsible for this adhesion. Unstimulated cells express the vitronectin receptor on their surface and this beta 3 integrin molecule contributes to adhesion. Another putative receptor for TSP, termed glycoprotein (GP) 88, which exists as a cytoplasmic pool in unstimulated cells becomes surface expressed when these cells are plated on TSP and localizes to areas of cell adhesion. Western blot analysis of cell lysate confirms GP88 as a TSP binding protein. Studies with fucoidan indicate that the heparan sulfate proteoglycan, known to function as a receptor for TSP, appears to contribute substantially to the TSP attachment of these cells and may be the receptor most important in the initial phases of TSP interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370062     DOI: 10.1016/0014-4827(92)90152-x

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36.

Authors:  Yuben Moodley; Paul Rigby; Chris Bundell; Stuart Bunt; Hideyuki Hayashi; Neil Misso; Robin McAnulty; Geoffrey Laurent; Amelia Scaffidi; Philip Thompson; Darryl Knight
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes.

Authors:  D Fischer; R P Tucker; R Chiquet-Ehrismann; J C Adams
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

3.  Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.

Authors:  P Clezardin; J Lawler; J Amiral; G Quentin; P Delmas
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

4.  Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Authors:  Jason A Bush; Hideki Kitaura; Yuliang Ma; Steven L Teitelbaum; F Patrick Ross; Jeffrey W Smith
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

5.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas.

Authors:  M Streit; P Velasco; L F Brown; M Skobe; L Richard; L Riccardi; J Lawler; M Detmar
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.

Authors:  J C Adams; J Lawler
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

8.  Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis.

Authors:  T R Kyriakides; Y H Zhu; L T Smith; S D Bain; Z Yang; M T Lin; K G Danielson; R V Iozzo; M LaMarca; C E McKinney; E I Ginns; P Bornstein
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

9.  Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family.

Authors:  J Lawler; M Duquette; C A Whittaker; J C Adams; K McHenry; D W DeSimone
Journal:  J Cell Biol       Date:  1993-02       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.